-
1 Comment
SEED Co.,Ltd is currently in a long term uptrend where the price is trading 12.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
SEED Co.,Ltd's total revenue rose by 6.6% to $8B since the same quarter in the previous year.
Its net income has increased by 312.4% to $593M since the same quarter in the previous year.
Finally, its free cash flow grew by 215.9% to $1B since the same quarter in the previous year.
Based on the above factors, SEED Co.,Ltd gets an overall score of 5/5.
| Exchange | TSE |
|---|---|
| CurrencyCode | JPY |
| ISIN | JP3347000006 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Beta | 0.0 |
|---|---|
| Dividend Yield | 2.6% |
| Market Cap | 17B |
| PE Ratio | 15.78 |
| Target Price | None |
SEED Co.,Ltd. manufactures and sells contact lenses and care products in Japan. The company offers daily disposable contact lenses; bi-weekly/monthly contact lenses; rigid gas permeable contact lenses; and medical contact lenses, including orthokeratology and iris lens. It also provides multipurpose solution (MPS) for soft contact lenses; and pharmaceutical products, such as Adeno Test AD, an adenovirus antigen detection agent, and other products. The company was incorporated in 1957 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7743.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026